Tempus AI stock price surged to a record high on Wednesday after the healthcare-focused artificial intelligence company announced a major breakthrough from the Food and Drug Administration (FDA). It jumped to a high of $91, which coincided with the highest point in February this year.Why Tempus AI stock is soaring Tempus…
Friday’s news wrap covers major developments shaping global politics, technology, and security. A suspect has been arrested in the…
AstraZeneca has become the latest major drugmaker to scale back investment in the United Kingdom, pausing a planned £200…
With US equities hovering near record levels and economics indicators flashing warning signs – Morgan Stanley is urging investors…
Markets ended the week with a mix of corporate developments, economic data, and breaking news shaping investor sentiment. Tesla…
The world’s largest asset manager is set to use President Donald Trump’s state visit to the United Kingdom next…
Oracle’s historic stock surge this week underscored the central role OpenAI continues to play in global technology markets. The…
A day of significant developments is underway across the Asia-Pacific, as a Wall Street giant makes a key strategic…
The International Energy Agency reported on Friday that the projected development of low-emissions hydrogen projects by 2030 has decreased…